EDGAR Filing Documents for 0001104659-17-026360

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:

SEC Accession No. 0001104659-17-026360

Filing Date

2017-04-26

Accepted

2017-04-26 16:11:15

Documents

Effectiveness Date

2017-04-26

Document Format Files

Seq	Description	Document	Type	Size
1	DEFA14A	a17-2447_3defa14a.htm	DEFA14A	32600
2	GRAPHIC	g24473bci001.jpg	GRAPHIC	117363
3	GRAPHIC	g24473bci002.jpg	GRAPHIC	182311
4	GRAPHIC	g24473bci003.jpg	GRAPHIC	68243
5	GRAPHIC	g24473bci004.jpg	GRAPHIC	26880
	Complete submission text file	0001104659-17-026360.txt		577676

Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139

Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971

CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)